Genomictree Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported negative sales was KRW 0.0003 million compared to sales of KRW 0.00007 million a year ago. Net loss was KRW 6,630.82 million compared to KRW 11,424.52 million a year ago.

Basic loss per share from continuing operations was KRW 316 compared to KRW 553 a year ago. Diluted loss per share from continuing operations was KRW 316 compared to KRW 553 a year ago. Basic loss per share was KRW 316 compared to KRW 553 a year ago.